JPRN-UMIN000024610已完成未知
Phase 2 prospective study of the efficacy of nab-paclitaxel, carboplatin and bevacizumab for the treatment of stage 3B/4 non-squamous cell and non-small cell lung cancer - Phase 2 study of nab-paclitaxel, carboplatin and bevacizumab for the treatment of non-squamous and non-small cell lung cancer
niversity of Fukui0 个研究点目标入组 30 人开始时间: 2016年11月1日最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 发起方
- 入组人数
- 30
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 20years-old 至 75years-old（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •1) Brain metastasis accompnied by significant symptoms. 2) Hemoptysis 3) Allergy or hypersensitibity against the medicines in this trial or albumin. 4) Peripheral neuropathy (grade 2 or more) before the treatment. 5) Uncontrolled effusion. 6) Palliative radiation within 2 weeks. 7) Operation within 4 weeks. 8) Active double cancer 9) High body temperature (38 degrees Celsius and more). 10) Severe complications. 11) Anti-coagulation therapy 12) Pregnant woman 13) HBs antigen positive 14) The subjects whom the doctor excluded.
研究者
相似试验
进行中（未招募）
1 期
Phase II, open-label, non-randomized study of nab-paclitaxel for the neoadjuvant treatment of patients with stage II and III luminal breast cancer.eoadjuvant tratment of patients with stage II - III luminal brest cancerMedDRA version: 14.0 Level: PT Classification code 10057654 Term: Breast cancer female System Organ Class: 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)EUCTR2011-004476-10-ESFundación Grupo Español de Investigación en Cáncer de Mama (Fundación GEICAM)78
已完成
不适用
Phase II Study for Efficacy and Safety of nab-paclitaxel for Previously Treated Advanced Non-small Cell Lung Cancerlung cancerJPRN-UMIN000010737Tokyo Metropolitan Cancer and Infection diseases Center Komagome Hospital22
已完成
2 期
A phase II study to investigate the efficacy of neoadjuvant erlotinib in patients with clinical stage I/II non-small cell lung cancer (NSCLC)early stage lung cancernon-small cell lung cancer stage I/II10038666NL-OMON29708Antoni van Leeuwenhoek Ziekenhuis55
进行中（未招募）
不适用
A pilot phase II study to assess the efficacy of Brentuximab Vedotin administered sequentally with ABVD chemotherapy in patients with untreated Hodgkin LymphomaEUCTR2012-002012-46-ITAZIENDA OSPEDALIERA POLICLINICO DI MODENA
尚未招募
不适用
Probiotics for patients with cancersCTRI/2021/03/032021Christian Medical College Vellore